Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclopirox olamine cream versus Batrafen cream versus vehicle in skin mycoses
2018-001633-41Phase 3Completed
- Sponsor
- Dermapharm
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ciclopirox in dermatomycosis (3 arms), sponsored by Dermapharm. Primary endpoint: Primary efficacy endpoint. Started Dec 2018; status: completed.
02
Drugs
ciclopirox
03
Conditions
dermatomycosis
Beyond the preview
Go deeper on 2018-001633-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001633-41.